NDC11 00069030801
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00069-0308-01 | 00069-0308 |
| 00069-0308-1 | 00069-0308 |
| 00069-308-01 | 00069-308 |
| 0069-0308-01 | 0069-0308 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Trazimera | TRASTUZUMAB-QYYP | Pfizer Laboratories Div Pfizer Inc | b9c5e894-27d2-4245-a653-df986fed3c56 | 2026-04-10 | Boxed warning, Warnings, Adverse reactions | 0069-0308-01 0069-0308 00069030801 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.